47 results
10-K
2023 FY
TCBP
TC BioPharm (Holdings) plc
1 Apr 24
Annual report
5:11pm
patient access.
Expand our intellectual property portfolio and acquire additional technologies to augment our strong IP position
We intend … and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing
8-K
EX-99.1
TCBP
TC BioPharm (Holdings) plc
14 Feb 24
TCBP Provides Shareholder Update and Highlights Upcoming Milestones
2:48pm
. This relates to being positioned to effectively execute our business strategy over the coming 90 days, both in the M&A arena and access to capital
6-K
EX-10.4
TCBP
TC BioPharm (Holdings) plc
21 Dec 23
TC BioPharm Announces Pricing of $3.5 Million Public Offering
5:14pm
to permit preparation of financial statements in conformity with IFRS and to maintain asset accountability, (iii) access to assets is permitted only … and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would
424B4
TCBP
TC BioPharm (Holdings) plc
20 Dec 23
Prospectus supplement with pricing info
6:42pm
with patients and healthcare professionals, whilst continually seeking to reduce manufacturing costs to improve patient access.
We intend to continue
F-1/A
TCBP
TC BioPharm (Holdings) plc
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
seeking to reduce manufacturing costs to improve patient access.
We intend to continue building on our technology platform, comprised of intellectual
F-1/A
EX-10.7
n2jrvdr3m3fqwg
12 Dec 23
Registration statement (foreign) (amended)
9:34pm
424B3
360xg qbaofi6
8 Nov 23
Prospectus supplement
4:05pm
F-3/A
qv9cz
2 Nov 23
Shelf registration (foreign) (amended)
1:11pm
F-3
5ky7oatgjp887cyaqzf
29 Sep 23
Shelf registration (foreign)
4:05pm
F-1
ndswx
28 Aug 23
Registration statement (foreign)
5:25pm
6-K
EX-99.4
5vr1bv umf
7 Jun 23
Current report (foreign)
4:10pm
6-K
EX-10.4
02a6fxdaqlie9c6w
30 Mar 23
TC BioPharm Announces Pricing of $5.5 Million Public Offering
5:10pm
424B4
s46j9ersz3l6t
29 Mar 23
Prospectus supplement with pricing info
5:01pm
424B3
l46po7qe8jc4
27 Dec 22
Prospectus supplement
4:05pm
F-1
6k1ws35w
12 Dec 22
Registration statement (foreign)
4:02pm
6-K
EX-10.5
p7m ydbn7
30 Nov 22
Current report (foreign)
8:58am
6-K
EX-10.4
5ommtnd94ljvqrysex6
30 Nov 22
Current report (foreign)
8:58am
424B1
0qmg uwuj4
3 Jun 22
Prospectus with pricing info
2:33pm
F-1/A
EX-1.1
unwh2por8dstf
31 May 22
Registration statement (foreign) (amended)
4:55pm